跳至主要内容
临床试验/JPRN-UMIN000048621
JPRN-UMIN000048621招募中未知

Add-on imeglimin versus metformin dose escalation regarding blood glucose fluctuation in patients with type 2 diabetes treated with low-dose metformin - Add-on imeglimin versus metformin dose escalation regarding blood glucose fluctuation in patients with type 2 diabetes treated with low-dose metformin

Hokkaido University Hospital0 个研究点目标入组 20 人开始时间: 2022年8月8日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 90years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) History of anaphylaxis of imeglimin or metformin 2) Unstable diabetic retinopathy 3) Severe hepatic dysfunction, renal dysfunction(eGFR<45 mL/min/1.73m2) 4) Pregnancy 5) Diabetic ketosis, coma and precoma 6) Serious infection, pre-or post-surgery 7) Poor adherence to dietary therapy 8) Poor insulin secretion 9) Patients who thought to be inappropriate to enter this study for some reasons by physician's judgments

研究者

相似试验